US Patent Issued to SHENZHEN ALPHA BIOPHARMACEUTICAL on June 10 for "Method of inducing dedifferentiation of somatic cells with small molecules to prepare rejuvenated mesenchymal stem cells and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,324,817, issued on June 10, was assigned to SHENZHEN ALPHA BIOPHARMACEUTICAL Co. LTD. (Shenzhen, China).

"Method of inducing dedifferentiation of somatic cells with small molecules to prepare rejuvenated mesenchymal stem cells and uses thereof" was invented by Min Hu (Yunnan, China), Yanjiao Li (Yunnan, China) and Junyuan Hu (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A preparation method and applications of rejuvenated and regenerative fibroblasts, where the rejuvenated and regenerative fibroblasts are prepared from normal fibroblasts by inhibiting the JAK-STAT signaling pathway. The rejuvenated and regenerative fibroblasts are pre...